At Genentech, we take a rigorous, comprehensive approach to understanding cancer biology and drug discovery so that we can continue to develop novel medicines for people with serious unmet medical needs.
We're constantly growing our expertise in Immunology so that we can continue to discover and develop innovative medicines for patients living with debilitating diseases, such as rheumatoid arthritis or asthma.
Our Neuroscience Research and Drug Discovery program is aimed at discovering and developing breakthrough medicines for patients with major diseases of the nervous system, such as Alzheimer's diseases.
We're committed to discovering and developing innovative medicines for metabolic diseases. So we focus on creating new treatment options for patients with diabetes, as well as ways to prevent major adverse cardiovascular events in patients with acute coronary syndrome.
Recently, we've seen an explosion of new information about the basic biology of pathogens and how a host responds to infection. We're using this new information to develop new medicines and technologies that combat serious bacterial and viral infections, such as HCV.
